MLH3:: a DNA mismatch repair gene associated with mammalian microsatellite instability

被引:239
作者
Lipkin, SM
Wang, V
Jacoby, R
Banerjee-Basu, S
Baxevanis, AD
Lynch, HT
Elliott, RM
Collins, FS [1 ]
机构
[1] NIH, Natl Ctr Human Genome Res Inst, Genet & Mol Biol Branch, Bethesda, MD 20892 USA
[2] NIH, Natl Ctr Human Genome Res Inst, Genome Technol Branch, Bethesda, MD 20892 USA
[3] Univ Wisconsin, Dept Med, Div Gastroenterol, Madison, WI USA
[4] New York State Dept Hlth, Roswell Pk Canc Inst, Buffalo, NY 14263 USA
[5] Creighton Univ, Hereditary Canc Inst, Omaha, NE 68178 USA
关键词
D O I
10.1038/71643
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
DNA mismatch repair is important because of its role in maintaining genomic integrity and its association with hereditary non-polyposis colon cancer (HNPCC). To identify new human mismatch repair proteins, we probed nuclear extracts with the conserved carboxy-terminal MLH1 interaction domain. Here we describe the cloning and complete genomic sequence of MLH3, which encodes a new DNA mismatch repair protein that interacts with MLH1. MLH3 is more similar to mismatch repair proteins from yeast, plants, worms and bacteria than to any known mammalian protein, suggesting that its conserved sequence may confer unique functions in mice and humans. Cells in culture stably expressing a dominant-negative MLH3 protein exhibit microsatellite instability. MIh3 is highly expressed in gastrointestinal epithelium and physically maps to the mouse complex trait locus colon cancer susceptibility I (Ccs1). Although we were unable to identify a mutation in the protein-coding region of MIh3 in the susceptible mouse strain, colon tumours from congenic Ccs1 mice exhibit microsatellite instability. Functional redundancy among MIh3, Pms1 and Pms2 may explain why neither Pms1 nor Pms2 mutant mice develop colon cancer, and why PMS1 and PMS2 mutations are only rarely found in HNPCC families.
引用
收藏
页码:27 / 35
页数:9
相关论文
共 49 条
[1]  
Akiyama Y, 1997, CANCER RES, V57, P3920
[2]   Gapped BLAST and PSI-BLAST: a new generation of protein database search programs [J].
Altschul, SF ;
Madden, TL ;
Schaffer, AA ;
Zhang, JH ;
Zhang, Z ;
Miller, W ;
Lipman, DJ .
NUCLEIC ACIDS RESEARCH, 1997, 25 (17) :3389-3402
[3]   Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent [J].
Andrew, SE ;
McKinnon, M ;
Cheng, BS ;
Francis, A ;
Penney, J ;
Reitmair, AH ;
Mak, TW ;
Jirik, FR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (03) :1126-1130
[4]  
[Anonymous], 1978, ATLAS PROTEIN SEQ ST
[5]   Involvement of mouse Mlh1 in DNA mismatch repair and meiotic crossing over [J].
Baker, SM ;
Plug, AW ;
Prolla, TA ;
Bronner, CE ;
Harris, AC ;
Yao, X ;
Christie, DM ;
Monell, C ;
Arnheim, N ;
Bradley, A ;
Ashley, T ;
Liskay, RM .
NATURE GENETICS, 1996, 13 (03) :336-342
[6]   Human type 1 diabetes and the insulin gene: Principles of mapping polygenes [J].
Bennett, ST ;
Todd, JA .
ANNUAL REVIEW OF GENETICS, 1996, 30 :343-370
[7]   Competency in mismatch repair prohibits clonal expansion of cancer cells treated with N-methyl-N'-nitro-N-nitrosoguanidine [J].
Carethers, JM ;
Hawn, MT ;
Chauhan, DP ;
Luce, MC ;
Marra, G ;
Koi, M ;
Boland, CR .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (01) :199-206
[8]   The human type I collagen mutation database [J].
Dalgleish, R .
NUCLEIC ACIDS RESEARCH, 1997, 25 (01) :181-187
[9]   INACTIVATION OF THE MOUSE MSH2 GENE RESULTS IN MISMATCH REPAIR DEFICIENCY, METHYLATION TOLERANCE, HYPERRECOMBINATION, AND PREDISPOSITION TO CANCER [J].
DEWIND, N ;
DEKKER, M ;
BERNS, A ;
RADMAN, M ;
RIELE, HT .
CELL, 1995, 82 (02) :321-330
[10]   Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment [J].
Drazen, JM ;
Yandava, CN ;
Dubé, L ;
Szczerback, N ;
Hippensteel, R ;
Pillari, A ;
Israel, E ;
Schork, N ;
Silverman, ES ;
Katz, DA ;
Drajesk, J .
NATURE GENETICS, 1999, 22 (02) :168-170